Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin in Stable COPD (RODEO)
NCT00929734Phase 2
Key facts
- Status
- Completed
- Start
- Mar 2010
- Primary completion
- Jan 2014
- Countries
- 1
- Modality
- Orthosteric Ligands
- Drugs
- rosuvastatin
- Conditions
- chronic obstructive pulmonary disease (COPD)
01
Overview
Phase 2, randomised, double-blind trial of rosuvastatin in chronic obstructive pulmonary disease (COPD). Started Mar 2010; status: completed.
02
Design
- Study design
- RandomizedDouble-blind
03
Results
Not all primary endpoints met
04
Registry description
The purpose of this study is to investigate whether rosuvastatin improves measures of endothelial function, decreases measures of inflammation, and improves pulmonary function in patients with stable chronic obstructive pulmonary disease.
Beyond the preview
Go deeper on NCT00929734.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00929734.